157: Therapeutic Choices in Patients with Ph1 (+) Chronic Myelogenous Leukemia Living in Developing Countries in the Tyrosine Kinase Inhibitors (TKI) Era: Stem Cell Transplantation or TKI?
作者： GJ Ruiz-Arguelles , LC Tarin-Arzaga , ML Gonzalez-Carrillo , KI Gutierrez-Riveroll , R Rangel-Malo
DOI: 10.1016/J.BBMT.2007.12.166
关键词:
摘要:
core.ac.uk
bbmt.org
elsevier.com参考文章(0)